Bullous acral eruption related to secukinumab.

Bullous acral eruption related to secukinumab.
Dermatol Online J. 2019 Jun 15;25(6):
Authors: Blackcloud P, Dupuy E, Kang Y, Smart C, Hsiao J
Abstract
Skin reactions related to secukinumab are uncommon. Although the initial phase 3 studies of this medication reported infection and urticaria as adverse cutaneous events, other cases of unique adverse events have since been reported. We are presenting a patient who developed an exuberant hand and foot reaction after starting secukinumab.
PMID: 31329391 [PubMed - in process]

Source: Dermatol Online J - June 14, 2019 Category: Dermatology Authors: Blackcloud P, Dupuy E, Kang Y, Smart C, Hsiao J Tags: Dermatol Online J Source Type: research